EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:77108 - EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD+)] inhibitor
| ChEBI ID | CHEBI:77108 |
| ChEBI Name | EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD+)] inhibitor |
| Stars | |
| ASCII Name | EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor |
| Definition | An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that interferes with the action of 15-hydroxyprostaglandin dehydrogenase (NAD+) (EC 1.1.1.141). |
| Last Modified | 13 December 2017 |
| Submitter | Gareth Owen |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD+)] inhibitor (CHEBI:77108) is a EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor (CHEBI:76835) |
| Incoming Relation(s) |
| berberine (CHEBI:16118) has role EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD+)] inhibitor (CHEBI:77108) |
| CAY10397 (CHEBI:138839) has role EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD+)] inhibitor (CHEBI:77108) |
| Synonyms | Source |
|---|---|
| NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors | ChEBI |
| PGDH inhibitor | ChEBI |
| prostaglandin dehydrogenase inhibitor | ChEBI |
| (5Z,13E)-(15S)-11α,15-dihydroxy-9-oxoprost-13-enoate:NAD+ 15-oxidoreductase inhibitor | ChEBI |
| (5Z,13E,15S)-11α,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD+ 15-oxidoreductase inhibitors | ChEBI |
| 15-hydroxyprostaglandin dehydrogenase (NAD+) (EC 1.1.1.141) inhibitor | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 15-hydroxyprostaglandin_dehydrogenase_(NAD%2B) | Wikipedia |
| Citations |
|---|